CANDID-CNS is 1910's AI model for predicting small-molecule blood-brain barrier penetration in beyond-Rule-of-5 chemical space.
CANDID-CNS is a state-of-the-art AI model that predicts blood-brain barrier (BBB) penetration for small molecules, including beyond-Rule-of-5 (bRo5) compounds and stereoisomers. Trained on multimodal data, it outperforms the industry-standard CNS-MPO score on benchmarks for both Ro5 and bRo5 chemical space.
The model expands oral drug opportunities for central nervous system therapeutics by distinguishing brain-penetrant from non-penetrant candidates early in discovery, and is available for partnership through 1910's platform.
Simulations Plus
ADMET Predictor
simulations-plus.com
Insitro
AI Drug Discovery Platform
insitro.com
Schrödinger
Computational Molecular Discovery Platform
schrodinger.com
| Attribute | Candid-Cns | ADMET Predictor | AI Drug Discovery Platform | Computational Molecular Discovery Platform | |
|---|---|---|---|---|---|
| Provider |  | | | | |
| Founded | 2018 | 1996 | 2018 | 1990 | |
| Sells To | Enterprise, Pharmaceutical | Enterprise | Enterprise | Enterprise | |
| Pricing Model | Licensing | Recurring, Software | Recurring | Recurring, Software, Transactional | |
| Ownership | Venture-backed | Public | Private equity-backed, Venture-backed | Public |
Provider
Founded 2018
Sells To Enterprise, Pharmaceutical
Pricing Model Licensing
Ownership Venture-backed
Provider
Founded 1996
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Public
Provider
Founded 2018
Sells To Enterprise
Pricing Model Recurring
Ownership Private equity-backed, Venture-backed
Provider
Founded 1990
Sells To Enterprise
Pricing Model Recurring, Software, Transactional
Ownership Public
Biomedical AI platform that grounds biopharma R&D decisions in validated biology.
Autonomous AI agents that orchestrate and run scientific research workflows.
Beacon-2 is Inductive Bio dose-prediction model family ranking compounds by predicted human dose.
Compass is Inductive Bio virtual bench platform embedding AI models, lab automation, and chemists in small-molecule discovery.
ToxAI is a cloud software suite that uses AI models to predict chemical toxicity across millions of compounds.
Magritte turns material specifications into quantum simulation circuits through Phasecraft's automated software pipeline.
Indy is Inductive Bio AI chemistry assistant guiding chemists through design, synthesis, and assay decisions.
Biomedical AI platform that grounds biopharma R&D decisions in validated biology.
Autonomous AI agents that orchestrate and run scientific research workflows.
Beacon-2 is Inductive Bio dose-prediction model family ranking compounds by predicted human dose.
Compass is Inductive Bio virtual bench platform embedding AI models, lab automation, and chemists in small-molecule discovery.
ToxAI is a cloud software suite that uses AI models to predict chemical toxicity across millions of compounds.
Magritte turns material specifications into quantum simulation circuits through Phasecraft's automated software pipeline.
Indy is Inductive Bio AI chemistry assistant guiding chemists through design, synthesis, and assay decisions.